Serelaxin, a 'breakthrough' investigational intravenous agent for acute heart failure

P T. 2013 Oct;38(10):606-11.

Authors

Marta A Miyares, Kyle A Davis

PMID: 24391379
PMCID: PMC3875246

Abstract

Recombinant relaxin (serelaxin), a breakthrough therapy for acute heart failure.